Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stability of Type 2 Inflammation in a 12-Year Adult-Onset Asthma Follow-Up Study.

Journal of asthma and allergy·2026
Same author

Bioimpedance spectroscopy uncovers extracellular fluid excess in primary aldosteronism.

European journal of endocrinology·2026
Same author

Transient receptor potential ankyrin 1 promotes the expression of interferon-stimulated antiviral genes in human A549 lung epithelial cells.

Molecular pharmacology·2026
Same author

Association of MMP-9 and TIMP-1 concentration with neurological outcome after cardiac arrest and resuscitation - a substudy of the COMACARE trial.

Resuscitation plus·2026
Same author

Repeated Intake of Grapefruit Juice Inhibits CYP2B6, CYP2C9, CYP2C19, and CYP3A4 while Lingonberry Powder Does Not Induce Major CYP Enzymes in Humans.

Clinical pharmacology and therapeutics·2025
Same author

Immunometabolic profiling in menopausal women with multiple sclerosis: the role of adipokines and hormone therapy.

BMJ neurology open·2025

Related Experiment Video

Updated: Jul 2, 2026

Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry
08:07

Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry

Published on: July 26, 2019

Calcineurin inhibitors down-regulate iNOS expression by destabilizing mRNA.

Mari Hämäläinen1, Riku Korhonen, Eeva Moilanen

  • 1The Immunopharmacology Research Group, University of Tampere Medical School and Tampere University Hospital, Research Unit, Tampere, Finland. mari.j.hamalainen@uta.fi

International Immunopharmacology
|August 12, 2008
PubMed
Summary

Calcineurin inhibitors like cyclosporin A suppress nitric oxide (NO) production by reducing inducible nitric oxide synthase (iNOS) mRNA decay. These findings enhance understanding of immunosuppressive drug anti-inflammatory mechanisms.

More Related Videos

Extraction and Quantification of Soluble, Radiolabeled Inositol Polyphosphates from Different Plant Species using SAX-HPLC
09:01

Extraction and Quantification of Soluble, Radiolabeled Inositol Polyphosphates from Different Plant Species using SAX-HPLC

Published on: June 26, 2020

Absolute Quantitation of Inositol Pyrophosphates by Capillary Electrophoresis Electrospray Ionization Mass Spectrometry
09:22

Absolute Quantitation of Inositol Pyrophosphates by Capillary Electrophoresis Electrospray Ionization Mass Spectrometry

Published on: August 13, 2021

Related Experiment Videos

Last Updated: Jul 2, 2026

Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry
08:07

Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry

Published on: July 26, 2019

Extraction and Quantification of Soluble, Radiolabeled Inositol Polyphosphates from Different Plant Species using SAX-HPLC
09:01

Extraction and Quantification of Soluble, Radiolabeled Inositol Polyphosphates from Different Plant Species using SAX-HPLC

Published on: June 26, 2020

Absolute Quantitation of Inositol Pyrophosphates by Capillary Electrophoresis Electrospray Ionization Mass Spectrometry
09:22

Absolute Quantitation of Inositol Pyrophosphates by Capillary Electrophoresis Electrospray Ionization Mass Spectrometry

Published on: August 13, 2021

Area of Science:

  • Immunology
  • Pharmacology
  • Molecular Biology

Background:

  • Inflammation involves inducible nitric oxide synthase (iNOS) producing nitric oxide (NO), which has pro-inflammatory and cytotoxic effects.
  • Understanding the regulation of iNOS is crucial for developing anti-inflammatory therapies.

Purpose of the Study:

  • To investigate the effects of calcineurin inhibitors (cyclosporin A, tacrolimus, pimecrolimus) on NO production via the iNOS pathway.
  • To elucidate the molecular mechanisms underlying the anti-inflammatory actions of these immunosuppressive drugs.

Main Methods:

  • Assessed NO production and iNOS expression in activated macrophages and fibroblasts treated with calcineurin inhibitors.
  • Analyzed the impact on transcription factors NF-kappaB and STAT-1.
  • Quantified iNOS mRNA levels at different time points and examined the role of the 3'UTR in iNOS regulation using luciferase assays.

Main Results:

  • Calcineurin inhibitors demonstrated a concentration-dependent inhibition of NO production and iNOS expression.
  • Cyclosporin A was more potent than tacrolimus and pimecrolimus.
  • Inhibition was linked to enhanced decay of iNOS mRNA, dependent on the 3'UTR, without affecting NF-kappaB or STAT-1 activation.

Conclusions:

  • Calcineurin inhibitors suppress iNOS expression and NO production by promoting iNOS mRNA degradation.
  • These findings reveal a novel mechanism of action for immunosuppressive drugs, highlighting the role of calcineurin in regulating iNOS.
  • The results contribute to understanding the anti-inflammatory effects of cyclosporin A, tacrolimus, and pimecrolimus.